- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Fonar Corporation (FONR)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: FONR (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -1.54% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 93.69M USD | Price to earnings Ratio 11.9 | 1Y Target Price - |
Price to earnings Ratio 11.9 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1 | 52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 |
52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.25 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.19% | Operating Margin (TTM) 13.48% |
Management Effectiveness
Return on Assets (TTM) 3.54% | Return on Equity (TTM) 6.91% |
Valuation
Trailing PE 11.9 | Forward PE - | Enterprise Value 78089814 | Price to Sales(TTM) 0.91 |
Enterprise Value 78089814 | Price to Sales(TTM) 0.91 | ||
Enterprise Value to Revenue 0.76 | Enterprise Value to EBITDA 3.37 | Shares Outstanding 6168460 | Shares Floating 6030734 |
Shares Outstanding 6168460 | Shares Floating 6030734 | ||
Percent Insiders 2.45 | Percent Institutions 49.08 |
Upturn AI SWOT
Fonar Corporation

Company Overview
History and Background
Fonar Corporation, founded in 1978 by Dr. Raymond Damadian, is a pioneer in Magnetic Resonance Imaging (MRI) technology. Dr. Damadian is credited with inventing the MRI scanner and is the founder of the first MRI-specific diagnostic imaging center in the United States. Over the years, Fonar has focused on developing and manufacturing MRI scanners and has also operated diagnostic imaging centers.
Core Business Areas
- MRI Scanner Manufacturing: Fonar designs, manufactures, and sells advanced MRI scanners. These scanners are designed with specific features that differentiate them from competitors, often focusing on open and upright designs to improve patient comfort and accessibility for specific diagnostic needs.
- Diagnostic Imaging Services: Fonar operates diagnostic imaging centers that utilize its own MRI scanners to provide MRI scans to patients. These centers generate revenue through the performance of these scans.
Leadership and Structure
The leadership of Fonar Corporation is heavily influenced by its founder, Dr. Raymond Damadian, who has historically held key leadership positions. The company is structured to manage its manufacturing operations and its network of diagnostic imaging centers.
Top Products and Market Share
Key Offerings
- Fonar UPRIGHTu00ae Multi-Positionu2122: The UPRIGHTu00ae Multi-Positionu2122 MRI scanner is a flagship product, offering patients the ability to be scanned in various positions (standing, sitting, lying down), which can reveal conditions not seen in conventional supine MRI. Market share data specifically for this product is not publicly disclosed. Key competitors in the broader MRI scanner market include GE Healthcare, Siemens Healthineers, and Philips.
- Fonar ENCOREu00ae MRI Systems: These systems offer advanced imaging capabilities and are designed for various clinical applications. Similar to the UPRIGHT system, specific market share figures are not readily available. Competitors include the same major medical imaging companies.
Market Dynamics
Industry Overview
The medical imaging industry, particularly MRI, is a mature but continually evolving sector driven by technological advancements, increasing demand for diagnostic imaging, and healthcare spending. Competition is intense, with a few large global players dominating the market. There is a growing emphasis on specialized imaging solutions and improved patient experience.
Positioning
Fonar's positioning is characterized by its pioneering role in MRI and its focus on differentiated MRI scanner designs, such as open and upright configurations, which cater to specific diagnostic needs and patient comfort. Its vertical integration, owning both scanner manufacturing and imaging centers, is a unique aspect of its business model. However, it faces significant competition from larger, more diversified medical technology companies.
Total Addressable Market (TAM)
The global MRI market is substantial and growing, projected to reach tens of billions of dollars. Fonar is a niche player within this large TAM, focusing on specific segments of the MRI market where its unique product offerings can provide an advantage. Its success is tied to capturing a segment of this market rather than broad market dominance.
Upturn SWOT Analysis
Strengths
- Pioneering MRI technology and intellectual property
- Unique open and upright MRI scanner designs
- Vertical integration with manufacturing and imaging centers
- Long-standing expertise and brand recognition in niche MRI areas
Weaknesses
- Relatively small market share compared to larger competitors
- Limited product portfolio breadth
- Potential reliance on a few key products
- Challenges in competing with the R&D budgets of larger players
Opportunities
- Growing demand for advanced diagnostic imaging
- Increased focus on patient comfort and accessibility in imaging
- Expansion of diagnostic imaging centers
- Technological advancements leading to new applications for MRI
Threats
- Intense competition from established global medical device manufacturers
- Rapid technological advancements by competitors
- Healthcare policy changes and reimbursement rates
- Economic downturns affecting healthcare spending
Competitors and Market Share
Key Competitors
- GE HealthCare (GEHC)
- Siemens Healthineers AG (SEM.DE)
- Philips (PHIA.AS)
Competitive Landscape
Fonar's advantages lie in its specialized, open MRI designs that cater to specific patient needs. However, it faces disadvantages against larger competitors who have greater financial resources for R&D, extensive global sales and service networks, and broader product portfolios across various medical imaging modalities. Fonar competes on its unique product differentiation and specialized market focus.
Growth Trajectory and Initiatives
Historical Growth: Fonar's historical growth has been influenced by its innovation in MRI technology and the expansion of its diagnostic imaging network. Growth has likely been steady but subject to market cycles and competitive pressures.
Future Projections: Future projections would depend on market demand for its specialized MRI scanners, the success of its diagnostic imaging centers, and its ability to compete with larger players. Analyst estimates, if available, would provide insights into expected revenue and earnings growth.
Recent Initiatives: Recent initiatives would typically involve new product development, enhancements to existing MRI systems, strategic partnerships, or expansion of its imaging center footprint.
Summary
Fonar Corporation is a niche player in the MRI market, leveraging its pioneering technology and unique upright scanner designs. Its strengths lie in innovation and vertical integration, while weaknesses include its smaller scale against global giants. The company has opportunities in growing diagnostic imaging demand but faces threats from intense competition and rapid technological shifts. Its ability to maintain its unique market position and execute its growth strategy will be key to its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Fonar Corporation Investor Relations (SEC Filings - 10-K, 10-Q)
- Industry Market Research Reports (General MRI Market)
- Financial News Outlets (for general industry trends)
Disclaimers:
This analysis is based on publicly available information and general market knowledge. Specific financial data, market share percentages, and competitor information may vary and are subject to change. This is not financial advice. Investors should conduct their own due diligence before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Fonar Corporation
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1987-01-01 | Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 520 | Website https://www.fonar.com |
Full time employees 520 | Website https://www.fonar.com | ||
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

